Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.16
Price to sales ratio
0.53

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4999
NCRA
Nocera, Inc. - common stock
1.75 USD-1.13%-6.42%-49.71%+18.24%3.74 M USD
5056
ATPC
Agape ATP Corporation - Common Stock
2.37 USD-1.25%-3.27%+2.16%+76.87%2.37 M USD
5120
FAMI
Farmmi, Inc. - Class A Ordinary Shares
0.10 USD0.00%0.00%-33.33%-92.29%548.19 K USD
5129
PAVS
Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares
5.42 USD+1.12%+5.45%+16.56%+632.43%426.73 K USD

Frequently asked questions about Arcadia Biosciences, Inc.

What is the Arcadia Biosciences, Inc. stock price today?

The current price of Arcadia Biosciences, Inc. (RKDA) is 0.51. Over the past 24 hours, the stock has changed by 0.00%. Follow the RKDA chart for real-time price dynamics.

What is the stock ticker of Arcadia Biosciences, Inc.?

Arcadia Biosciences, Inc. trades under the ticker RKDA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Arcadia Biosciences, Inc. stock going up?

RKDA has changed by +8.51% over the last week, -22.73% over the last month, and -86.86% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Arcadia Biosciences, Inc.?

Arcadia Biosciences, Inc. currently has a market capitalization of 1.23 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Arcadia Biosciences, Inc. earnings last quarter?

Last quarter, Arcadia Biosciences, Inc. reported earnings of -2.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Arcadia Biosciences, Inc. revenue for the last quarter?

Arcadia Biosciences, Inc. reported quarterly revenue of 1.45 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Arcadia Biosciences, Inc. net income for the last quarter?

Arcadia Biosciences, Inc. reported net income of -6.27 M for the last quarter. The previous quarter showed -4.38 M, which means net income changed by -42.90%.

How many employees does Arcadia Biosciences, Inc. have?

As of the latest available data, Arcadia Biosciences, Inc. has 8 employees. Workforce size can provide additional context about the company's scale and operations.

What is Arcadia Biosciences, Inc. EBITDA?

Arcadia Biosciences, Inc. EBITDA is -494 K, and its EBITDA margin is -34.19%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Arcadia Biosciences, Inc. stock?

You can buy Arcadia Biosciences, Inc. (RKDA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Arcadia Biosciences, Inc. stock?

Investing in Arcadia Biosciences, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RKDA chart and related analysis on metatrader.com as part of your research.

Arcadia Biosciences, Inc. - Common Stock

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation. It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.

News